Cross-Ancestry DNA Methylation Marks of Insulin Resistance in Pregnancy: An Integrative Epigenome-Wide Association Study.

"Duality of Interest. No potential conflicts of interest relevant to this article were reported."

"Funding. EPIPREG is supported by the South-Eastern Norway Regional Health Authority (grant 2019092), and the Norwegian Diabetes Association. BiB receives core infrastructure funding from the Wellcome Trust (WT101597MA), a joint grant from the UK Medical Research Council (MRC) and Economic and Social Science Research Council (MR/N024397/1), the British Heart Foundation (CS/16/4/32482), and the National Institute for Health Research under its Applied Research Collaboration for Yorkshire and Humber and the Clinical Research Network. DNA methylation data were funded by the UK MRC via the Integrative Epidemiology Unit (MC_UU_12013/5). H.R.E. works in the MRC Integrative Epidemiology Unit at the University of Bristol, which is supported by the MRC and the University of Bristol (MC_UU_00011/5). R.P.B. received funding form EFSD/Novo Nordisk Programme for Diabetes Research in Europe, the Swedish Research Council (2021-02623), and the Crafoord Foundation. The Botnia Study has been financially supported by grants from the Sigrid Juselius Foundation, Folkhalsan Research Foundation, Nordic Center of Excellence in Disease Genetics, EU (EXGENESIS), Finnish Diabetes Research Foundation, Foundation for Life and Health in Finland, Finnish Medical Society, Helsinki University Central Hospital Research Foundation, Perklén Foundation, Ollqvist Foundation, and Narpes Health Care Foundation. The study has also been supported by the Municipal Heath Care Center and Hospital in Jakobstad and Health Care Centers in Vasa, Narpes, and Korsholm."